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Macrophages play important roles in inflammation and host defense. The
metabolites of arachidonic acid (20:4) are important modulators of these re-
sponses (1). When macrophage phagocytic receptors interact with particulate
ligands such as immune complexes or bacteria, phospholipases are activated and
20:4 is released from membrane phospholipids (2, 3). The free 20:4 is then
oxygenated via the cyclooxygenase pathway to prostaglandin E2 (PGE2)' and
prostacyclin (PGI2) or along the lipoxygenase pathway to leukotriene C (LTC)
and hydroxyeicosatetraenoic acids (HETEs) (2-5). Little is known about the
molecular events underlying the regulation of 20 :4 metabolism.
We recently reported that bacterial LPS are poor triggers of the 20 :4 cascade
but do have the capacity to prime macrophages for greatly increased 20:4
metabolism upon subsequent stimulation (6). One second signal is phagocytosis
of latex beads. Latex can only trigger a LPS-primed cell (6). This led us to
postulate that activation of 20:4 metabolism in macrophages requires at least two
steps acting in sequence, a priming step followed by a triggering step (6).
Receptor-mediated particulate stimulation of the 20:4 cascade is capable of both
priming and triggering; LPS is capable of priming; and latex particles can only
generate the triggering step. We have reported data that suggest that the first,
priming step is related to LPS-dependent myristoylation of proteins involved in
signal-response coupling (7). We report here that the second, triggering step is
regulated by calcium. We further provide data that suggest that calcium also
regulates the lipoxygenase pathway.
Materials and Methods
Macrophage Cultures.
￿
Primary cultures of peritoneal macrophages were established
from resident cellsof specific pathogen-free female ICR mice (Trudeau Institute, Saranac
Lake, NY) weighing 25-30 g as previously described (6). Peritoneal cells (^-9 X 106/ml)
in MEM (Grand Island Biological Co., Grand Island, NY) containing 10% FCS were
added to 35-mm diameter plastic culture dishes (1 ml per dish). After 2 h at 37°C in 95%
air/5% C02, cultures were washed three times in calcium- and magnesium-free PBS (PD)
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kotriene C; PD, calcium- and magnesium-free PBS; PGE2, prostaglandin E2; PGI2, prostacyclin.
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to remove nonadherent cells. Fresh a-MEM plus 10% FCS (1 ml per dish) containing 0.5
ACi of 5,6,8,9,11,12,14,15-['H]arachidonic acid ([sH]20:4; sp act, 70 Ci/nmol; New
England Nuclear, Boston, MA) was added and the cells were incubated overnight (16 h).
Assay ofTotal ['H]20:4 Release.
￿
Macrophages, prelabeled with [sH]20 :4, were washed
four times in PD and were then overlaid with 1 ml of serum-free MEM plus or minus 10
ng/ml Salmonella abortus equi LPS (gift of Dr. C. Galanos, Max Planck Institute, Freiburg,
Federal Republic of Germany). After 60 min, the cells were challenged with 0 .1 AM
A23187 (Calbiochem-Behring Corp., La Jolla, CA) or 25 nM PMA (Sigma Chemical Co.,
St. Louis, MO) as indicated. At the times indicated, aliquots of medium were removed
and counted in Hydrofluor (National Diagnostics, Inc., Somerville, NJ). The cells were
washed in PD and scraped into 1 ml of Triton X-100. Portions of the cell lysates were
assayed for radiolabel content and protein was determined by the method of Lowry et al.
(8) with BSA as a standard.
Quantitation of /gHJ20:4 Metabolites.
￿
The 20:4 metabolites in the culture medium
were extracted as described previously (9). To 1 ml of medium was added 1 ml of ethanol
and 10 Al of 88% (wt/wt) formic acid, and the resultant solution was extracted twice with
1 ml of chloroform containing 0.005% (wt/vol) butylated hydroxytoluene (Sigma Chemical
Co.). The lower (chloroform) phase were combined, evaporated to dryness under nitrogen,
and the residue was dissolved in the appropriate starting solvent for further purification
by reverse-phase HPLC.
Concentrated medium extracts were applied to a column of Ultrasphere C-18 (4.6 mm
X 25 cm; Altex Scientific Inc., Berkeley, CA) (HPLC system 1). The column was eluted
at a rate of 1 ml/min with 60 ml of solvent 1 (methanol/0.01 M H3P0, [65 :35], vol/vol,
adjusted to pH 5.4 with ammonium hydroxide), followed by 40 ml of solvent 2 (metha-
nol/acetic acid, 100:0.01, vol/vol) (10, 11). For the characterization of the cyclooxygenase
metabolites, a duplicate extract was applied on HPLC system 2 using a Fatty Acid Analysis
Column (Waters Associates, Milford, MA). Prostaglandins were eluted at a flow rate of 2
ml/min with 120 ml of solvent 3 (water/acetonitrile/benzene/acetic acid, 76.7:23:0.2:0.1,
vol/vol/vol/vol), followed by 40 ml of solvent 2 (10, 12). Fractions from the HPLC were
collected at 1-min intervals, and the radiolabel content of whole fractions or aliquots was
measured by liquid scintillation counting in Hydrofluor. Corrections were made for
counting efficiency (^-40%). The recovery of 20:4 metabolites through extraction and
purification procedures was monitored using radiolabeled standards (6).
LPS Determination. All reagents and culture material were found to contain <0.1
ng/ml contaminating LPS using the limulus amebocyte lysate assay (Cape Cod Associates,
Woods Hole, MA).
Calculation ofFree Ca21 Concentration.
￿
Free Ca21 concentration was calculated at pH
7 .4 from the pKa values of H-EGTA, and MH-EGTA, where H and M indicate bound
H+ and metal ions (both Ca2' and Mgt+), respectively (13).
Results
Nonactivating Concentrations of Calcium Ionophore Trigger 20:4 Metabolism in
LPS-primed Macrophages. Resident peritoneal macrophages, labeled with [sH]-
arachidonic acid (20:4) and treated either with LPS (10 ng/ml) or Ca21 ionophore
at 0.1 AM did not release sH label to the medium over a 3-h period (Fig. IA).
On the other hand, when the cells were first primed with LPS (10 ng/ml) for 60
min and then challenged with A23187 there was a rapid release of a large
amount of 20:4 metabolites (Fig. 1 A). The order in which stimuli were added
was critical. When the cells were first challenged with A23187 and subsequently
treated with LPS no release of 20:4 metabolites was observed for 40 min after
which time 20:4 metabolite secretion ensued (Fig. 1 B).
The experiments reported here with 10 ng/ml LPS and 0 .1 AM A23187 were
representative for LPS concentrations of 5-500 ng/ml and for A23187 concen-25
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FIGURE 1.
￿
Effect of Ca" ionophore A23187 on 20:4 secretion in LPS-primed and control
macrophages. Murine resident peritoneal macrophages were isolated by peritoneal lavage and
labeled overnight with ['H]20:4 in a-MEM and 10% FCS (6). (A)The cellswere washed four
times with PBS and overlaid with a-MEM containing 10 ng/ml LPS (Q, x) or with a-MEM
alone (A, 0). After 60 min at 37°C in 95% air/5% COs, the cells were treated with 0.1 AM
A23187 in DMSO (Q, A) or with DMSO alone (x, p). The final concentration of A23187 or
DMSO had no effect on cellular morphology, protein content, or on the capacity of the
macrophages to exclude trypan blue. At the specified times, duplicatealiquots of the medium
were removed and counted. The cells were scraped twice in 0.5% Triton X-100, and the
radiolabel and protein content ofthe cell lysates were determined (6). Values are expressed as
percent of total cellular 20:4 released into the medium, and are means of triplicate cultures
(SEM <I0%). The profile of 20:4 metabolites secreted after 120 min are shown in Table 1.
(B) Theexperiment wasdone exactly as described forA, except that A23187 wasadded at 0
min and LPS was added after 60 min. (C) Macrophages were washed four times with PBS,
overlaid with a-MEM, and challenged with 25 nM PMA (A), 0.1 pM A23187 (x) or with a
combination of 25 nM PMA and 0.1 wM A23187 (Q). The time course of 20:4 metabolite
releasewasassayed and expressedas describedin Aandtheprofileof20:4 metabolites secreted
after 120 min is shown in Table 1. The dashed line (Q) is the calculated value of the sum of
PMA and A23187-induced 20:4 secretion.
trations of 0.05-0.5 uM (data not shown). Concentrations of LPS >1 jug/ml
triggered macrophages to secrete -8% of their cellular 20:4 as cyclooxygenase
products (Table I and reference 6) and concentrations of A23187 of 1 UM or
higher killed the cells and promoted the rapid release of 20:4 metabolites from
both LPS-primed and control macrophages (6).
To be sure that Ca
21 (and not A23187) was critical for the triggering step,
cells were cultured with LPS for 60 min and then exposed to A23187 in Ca2+-
free medium (Fig. 2A). In the absence of external Ca
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￿
Ca21 concentration dependence of
cyclooxygenase andlipoxygenase metabolite se-
cretion from LPS-primed macrophages. Mac-
rophages were isolated, labeled with ['H]20:4,
and treated with 10 ng/ml LPSas described in
Fig.
￿
1A.
￿
After 60 min, the medium was
changed to a-MEM minus Cat` containing 0.5
mM EGTA (EGTA medium, custom made by
K.C. Biological, Inc., Lenexa,KS); after70 min
A23187 was added were indicated (p, A), and
at 80 minCa
21 wasaddedsuch that the medium
free Ca2+ concentration was 1.8 x 10' M (13).
Time Imln)
￿
(A)Cat' wasomitted; (x) A23187 was omitted.
(B)Macrophages were treated in sequence with
LPS, EGTA medium, A23187, and Cat' as
described in A except that the amount of Cat'
addedwasvaried to yield the medium free Cat'
concentrations indicated on the x axis. The
cyclooxygenase metabolites (6-keto-PGF,Q and
PGE2)andthelipoxygenase products (LTC and
5-HETE) were determined as described in Ta-
ble 1, 40 min after addition of the Cat' (i.e.,
120 min after being treated with LPS). The
data represent the mean ± SD of four deter-
minations.
Log medium free -IC0211 IM)
secreted into the medium. On the addition of Ca
21 (free [Ca2+] = 1.8 x 10-3 M)
to the medium there was a rapid release of 20:4 metabolites, confirming that an
increase in intracellular Ca
21 triggers 20:4 metabolite secretion in the LPS-
primed cell.
PMA, an activator ofprotein kinase C, has previously been shown to synergize
with A23187 in stimulating macrophage 20:4 metabolism (14, 15). We therefore
compared the synergy of LPS and A23187 with that of PMA and A23187. PMA
alone promoted the release of^-8% of the cell-associated [3H]20:4 in 2 h, while
PMA in combination with nonactivating concentrations of A23187 stimulated
the secretion of -25% of cellular 20:4 (Fig. 1 C). The data reported in Fig. 1 C
are representative for PMA concentrations of 5-100 nM and A23187 concen-
trations of0.05-0.5 /M.
Calcium Ionophore Unmasks the Lipoxygenase Pathway.
￿
An additional role for
Ca2' became apparent whenwe examined the profileof20:4 metabolites secreted
from cells that were either treated with LPS alone, or sequentially treated with
LPS and A23187 (Table 1). High concentrations of LPS (1 )ug/ml) promoted the
release of only cyclooxygenase products (6-keto-PGFI., 54.3%; PGE2, 43.2%)
(Table 1) whereas macrophages treated sequentially with LPS and A23187
secreted, in addition, largequantities ofthe lipoxygenase product, LTC4 (32.3%).
This representeda 150-fold increase in LTC production. A similar shiftin profile
of20:4 metabolite secretion occured when macrophages were treated with PMA
and A23187 (14, 15) (Table 1). While PMA alone stimulated macrophages to
secrete only cyclooxygenase products, the combination of PMA and A23187
promoted the release of large amounts of LTC as well (Table 1). Therefore,TABLE 1
20:4 Metabolites Synthesized by LPS-primed and Control Macrophages in Response to a Variety
ofStimuli
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A23187 (0.1 AM)
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Macrophages were isolated and labeled overnight with ['H]20:4. The cells were washed, overlaid
with a-MEM, and then incubated with the following: LPS (1 wg/ml); LPS (10 ng/ml); A23187 (0.1
AM); LPS (10 ng/ml) for 60 min followed by A23187 (0.1 AM) for 60 min; PMA (25 nM); and a
combination of PMA (25nM)andA23187 (0.1 KM). After 120 min, 20:4 metabolites were extracted,
identified andquantitated by HPLC as described in Materials and Methods. Values areexpressedas
the percent of total ['H]20:4 secreted into the medium calculated on the basis of discernible peaks
above background. Thedata represent themean of four determinations and the SEM was <10%.
increasing the Ca21 concentration within macrophages with A23187 resulted in
the activation ofthe lipoxygenase pathway.
These data implied that the cyclooxygenase and lipoxygenase pathways had
different Ca21 requirements. We therefore used LPS-primed macrophages that
had been treated with A23187 in the absence ofexternal Ca2' as a model system
in which to titrate the Ca21 concentration dependence ofeach pathway (Fig. 2B).
Neither cyclooxygenase nor lipoxygenase metabolites were secreted in the ab-
sence of Ca21 in the medium. When Ca21 was titrated into the system, cyclooxy-
genase products were detected at lower medium Ca21 concentrations than were
lipoxygenase metabolites (Fig. 2B). The Ko.5 (apparent) for extracellular free
Ca21 was 3.6 X 10' M for cyclooxygenase metabolite secretion and 1 .5 X 10-s
M for lipoxygenase product release. These data do not represent exactKo.5 since
the ionophore only renders the cells partially permeable to Cat+, but do give a
good comparative assessment of the Ca2' requirements of the two pathways.
Macrophagessecrete prodigious quantitiesof20:4 metabolites whenstimulated
with a variety of particulate and soluble agonists (2-5). The molecular mecha-
nism(s) leading to the activation of the 20:4 cascade and those underlying the
differential synthesis of cyclooxygenase and lipoxygenase metabolites remain
obscure. In this paper we show that nonactivating concentrations of Ca21 iono-
phore trigger the rapid release of 20:4 metabolites from LPS-primed macro-
phages but not from nonprimed cells (Fig. 1 A). Macrophages must be incubated
with LPS for at least 40 min before A23187 becomes effective as a trigger (Fig.
1B). This correlates exactly with the amount of time required to fully prime
macrophages for enhanced 20:4 metabolism with LPS (6). In effect, a complex
stimulus like latex uptake behaves in a similar way to A23187 in our system (6).
Condition
Percent
'H label
released
Cyclooxygenase
6-Keto-
PCF,, PGEY
Lipoxygenase
LTC HETEs
Unre-
acted
20:4
LPS (1 leg/ml) 8.6 54.3 43 .2 <0.2 1.2 1.3
LPS (10 ng/ml) 2.0 51 .9 44.6 <0.2 1.4 2.1
A23187 (0.1 AM) 2.3 42.4 45 .7 <0.2 4.8 7.1
LPS (10 ng/ml)/ 25.0 22.5 36.8 32.3 5.4 3.0
A23187 (0.1 AM)
PMA (25 nM) 8.1 36.2 57.6 <0.2 1.6 4.6
PMA (25 nM)/ 26.0 24.9 33.7 31 .9 6.6 2.9628 ARACHIDONIC ACID METABOLISM REGULATION IN MACROPHAGES
It is therefore ofinterest that phagocytosis oflatex particles is accompanied by a
two- to threefold increase in the intracellular Ca2+ concentration from resting
levels of -100 nM (Aderem, A., unpublished observation). Regulation of trig-
gering by Ca' is also consistent with our previous finding that 20:4 metabolite
secretion in macrophages is completely dependent on extracellular Ca2+ (16) and
with the requirements of macrophage phospholipases for Ca2+ (17, 18).
The synergy between LPS and A23187 in activating macrophage 20:4 metab-
olism is reminiscent ofthat seen with PMA and A23187 (14, 15) (Fig. 1 C). This
suggests that LPS may prime macrophages for enhanced 20:4 metabolism via a
protein kinase C-dependent pathway and is consistent with the observation that
LPS activates partially purified protein kinase C (19). However, there are
differences in the effect ofLPSand PMA on macrophage 20:4 metabolism. First,
PMA alone triggers the secretion of modest amounts of 20:4 metabolites, while
LPS (10 ng/ml) does not (Fig. 1, A and C). Second, it is necessary to preexpose
macrophages to LPS for at least 40 min before the addition of A23187, while
PMA exerts its effect immediately (Fig. 1). We have recently shown that LPS
promotes the myristoylation of three macrophage proteins (7) one of which (Mr
68 X 10') is a substrate for protein kinase C (Aderem, A., K. Albert, M. Keum,
J. Wang, P. Greengard, and Z. Cohn, submitted for publication). We have
further shown that the myristoylated protein kinase C substrate becomes associ-
ated with the plasma membrane . Since protein kinase C is activated at the
membrane (20), we hypothesize that LPS priming results in the closer association
of protein kinase C and its substrate, which in turn results in a more efficient
Ca'-dependent activation of 20:4 metabolism .
We have also used the LPS-primed macrophage as a model system in which to
examine the regulation of the cyclooxygenase and lipoxygenase pathways. It is
well known that ;different ligands trigger the secretion of different proportions
of lipoxygenase and cyclooxygenase metabolites (6, 14, 21). Thus particulate
triggers such as zymosan and immune complexes promote the secretion oflarge
amounts oflipoxygenase and cyclooxygenase metabolites, while soluble agonists
such as PMA trigger the release of cyclooxygenase products alone (6, 14, 21).
These data were interpreted by Humes et al. (21) to indicate that particulate
stimuli mobilize a pool ofarachidonic acid that is accessible to both cyclooxygen-
ase and lipoxygenase pathways, while soluble stimuli promote the release of a
distinct pool of 20:4 that is only available to the cyclooxygenase pathway. More
recently, Tripp et al. (14) showed that PMA could promote the release of LTC4
when used in combination with low, nonactivating, concentrations of A23187.
They suggested that PMA does not mobilize sufficient intracellular Ca2+ to
activate the 5-lipoxygenase. Increasing the Ca21 concentration with A23187
activates the 5-lipoxygenase and results in the secretion of both prostaglandins
and leukotrienes. This interpretation is paradoxical since the phospholipase(s)
also requires Ca21 for activity (17, 18). This apparent paradox can be resolved if
the phospholipase(s) has a higher affinity for Ca21 than does the 5-lipoxygenase.
The soluble stimuli may then increase the Ca21 concentration sufficiently to
activate the phospholipase(s) but not sufficiently to activate the 5-lipoxygenase.
The data presented in Fig. 2B support this hypothesis; cyclooxygenase metabo-
lites are secreted at an order of magnitude lower Ca2+ concentration than areWe thank Douglas Marratta for excellent technical assistance.
Receivedfor publication 14 October 1987.
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lipoxygenase metabolites. Consistent with this, the Ko.5apparent (Ca
21) ofpurified
phospholipase C has been reported as 3 uM (22) compared with 20-100 UM for
the partially purified 5-lipoxygenase (23). Thus agonists that mobilize relatively
small amounts of intracellular Ca2+ such as PMA (24) promote the secretion of
only cyclooxygenase products, while particulate agonists that stimulate rather
larger increases in intracellular Ca2+ (25) cause the secretion of both cyciooxy-
genase and lipoxygenase products.
Summary
LPS, a major component of Gram-negative bacterial cell walls, prime macro-
phages for greatly enhanced arachidonic acid [20:4] metabolism when the cells
are subsequently stimulated. The LPS-primed macrophage has been used as a
model system in which to study the role of Ca2+ in the regulation of 20:4
metabolism. The Ca2+ ionophore A23187 (0.1 AM) triggered the rapid release
of 20:4 metabolites from LPS-primed macrophages but not from cells not
previously exposed to LPS. Macrophages required exposure to LPS for at least
40 min before A23187 became effective as a trigger. A23187 (0.1 AM) also
synergized with PMA in activating macrophage 20:4 metabolism. The PMA
effect could be distinguished from that of LPS since no preincubation with PMA
was required. A23187 greatly increased the amount of lipoxygenase products
secreted from LPS-primed macrophages, leukotriene C4 synthesis being in-
creased 150-fold. LPS-primed macrophages, partially permeabilized to Ca21 with
A23187, were used to titrate the Ca21 concentration dependence of the cycloox-
ygenase and lipoxygenase pathways. Cyclooxygenase metabolites were detected
at an order of magnitude lower Ca2+ concentration than were lipoxygenase
products. The data suggest that Cat+ regulates macrophage 20:4 metabolism at
two distinct steps: an increase in intracellular Ca.2+ regulates the triggering signal
and relatively higher Ca21 concentrations are required for 5-lipoxygenase activ-
ity.
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